GO
Loading...

Myriad Genetics Inc

More

  • Abbott, Boston Scientific Stents & Stuff Tuesday, 1 Jul 2008 | 10:33 AM ET
    Heart Stent

    So, I can now safely say, with complete confidence, that Food and Drug Administration approval of the new Abbott drug-coated stent will not happen in the second quarter. Recently, at least a couple of analysts have been telling clients a decision was getting pushed out until the third quarter and one suggested that Xience won't be launched until Q4.

  • Market Midterm: Healthcare Wednesday, 25 Jun 2008 | 6:30 PM ET

    Here's how you can play healthcare with either a McCain or Obama presidency!

  • Dow Falls Below 12,000 Friday, 20 Jun 2008 | 5:53 PM ET

    The Dow closed sharply lower Friday, registering its third triple-digit loss in four sessions. What's the "Word on the Street?"

  • Options Eye Alzheimer's, GM, AmeriCredit Thursday, 19 Jun 2008 | 8:26 AM ET

    Options are eyeing the drug sector's Alzheimer's treatments, according to one observer.

  • Dow Headed Below 12,000? Wednesday, 18 Jun 2008 | 5:48 PM ET

    Stocks closed lower again on Wednesday. For a time, the Dow traded below the 12,000 mark for the first time since mid-March. What's the "Word on the Street?"

  • Medical Breakthrough Boom Tuesday, 17 Jun 2008 | 6:11 PM ET

    On Tuesday we received word of three exciting medical advancements. Find out what’s happening and how to trade them.

  • Triage Trade: Pfizer Wednesday, 9 Apr 2008 | 6:33 PM ET

    Pfizer treats us for everything from high cholesterol to impotence but in an ironic twist, it’s very sick itself. What’s the prescription for getting shares of Pfizer out of triage?

  • Your First Move For Wednesday Apr. 9th Tuesday, 8 Apr 2008 | 6:51 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Stocks Fall on Recession Fears Tuesday, 8 Apr 2008 | 6:16 PM ET

    Plus, Intel drags down tech, breaking news from American Airlines and UPS and much more.

  • Alzheimer's Miracle? Monday, 7 Apr 2008 | 6:33 PM ET

    Shares of Wyeth and Elan surged Monday on the promise of a new Alzheimer's drug. Can you trade it?

  • Double In A Decade Tuesday, 26 Feb 2008 | 6:21 PM ET

    Healthcare spending is expected to nearly double to $4.3 trillion by 2017. Who’s most likely to benefit and can you trade it?

  • Your Health, Your Trade Wednesday, 10 Oct 2007 | 11:01 PM ET

    BREAKING: Reuters reports FDA panel backs drug-coated stents made by Medtronic (MDT).

  • Promising Drug Headlines Tuesday, 25 Sep 2007 | 11:32 AM ET

    Look for pharmaceutical and biotech companies to make news this week as a UBS industry conference kicks off in New York. Also, Merrill Lynch analysts believe pricing power for prescription drugs is returning. What’s the trade?

  • Neurochem And Alzheimer's: Breaking Code Not Easy Monday, 27 Aug 2007 | 2:35 PM ET

    Shares of Neurochem today are trading at a new low after the Canadian biotech announced its developmental drug for Alzheimer's didn't work well enough. It is the latest evidence that cracking the code of this complex disease is extremely challenging. We recently did a story on the drug called Alzhemed, the potential AD-drug market and other companies working on treatments/cures at a dementia conference in Washington, DC.

Most Popular Video

Wednesday, 16 Apr 2014 | 12:00 AM ET

GM unveils new models, hopes for strong sales this year After massive recalls, General Motors is pushing forward with new car models unveiled at the 2014 New York International Auto Show. CNBC's Phil LeBeau explains.

Friday, 11 Apr 2014 | 7:23 AM ET

Former Fed Chairman Ben Bernanke challenges Raghuram Rajan, Reserve Bank of India governor on his views about monetary policies, reports CNBC's Michelle Caruso-Cabrera.

Tuesday, 15 Apr 2014 | 5:40 PM ET

Jonathan Geller, BGR president and editor-in-chief, weighs in on the specifications for Amazon's newly announced 3-D smartphone.